CLINICAL_TRIALS
trial_result
· 2018-11-08
Clinical Trial Update: A Study of Aripiprazole Lauroxil (Also Known as ARISTADA TM) in Subjects With Schizophrenia [Phase 4]
Summary
Phase 4 clinical trial update for aripiprazole lauroxil (ARISTADA) in schizophrenia with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Alkermes, Inc. | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED | Results posted: 2018-11-08